Logan; Thomas Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Logan; Thomas Joseph.The latest application filed is for "novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor".

Company Profile

0.5.14

Logan; Thomas Joseph - Springfield PA
Logan; Thomas Joseph - Needham MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 And 49933 Molecules And Uses Therefor App 20110150860 - Curtis; Rory A.J. ; et al.	2011-06-23
ACTR-1, a novel human acyltransferase and uses thereof Grant 7,820,403 - Kapeller-Libermann , et al. October 26, 2	2010-10-26
ACTR-1, a novel human acyltransferase and uses thereof App 20100009384 - Kapeller-Libermann; Rosana ; et al.	2010-01-14
Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor App 20080241133 - Curtis; Rory A. J. ; et al.	2008-10-02
ACTR-1, a novel human acyltransferase and uses thereof Grant 7,410,785 - Kapeller-Libermann , et al. August 12, 2	2008-08-12
Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor App 20070059730 - Curtis; Rory A.J. ; et al.	2007-03-15
MID 4460, a human tyrosine phosphatase family member and uses therefor Grant 7,157,240 - Logan January 2, 2	2007-01-02
ACTR-1, a novel human acyltransferase and uses thereof App 20060121518 - Kapeller-Libermann; Rosana ; et al.	2006-06-08
ACTR-1 a novel human acyltransferase and uses thereof Grant 7,052,888 - Kapeller-Libermann , et al. May 30, 2	2006-05-30
Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210 App 20050142604 - Logan, Thomas Joseph ; et al.	2005-06-30
Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor App 20040157221 - Curtis, Rory A. J. ; et al.	2004-08-12
25934, a novel fatty acid desaturase and uses therefor Grant 6,686,185 - Logan , et al. February 3, 2	2004-02-03
Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor App 20040009501 - Curtis, Rory A. J. ; et al.	2004-01-15
Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210 App 20030152574 - Logan, Thomas Joseph ; et al.	2003-08-14
Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587,10183, 10550, 12680, 17921, 32248, 60489 or 93804 App 20030119742 - Galvin, Katherine M. ; et al.	2003-06-26
Methods of using 279, a human G protein-coupled protein receptor App 20030109044 - Logan, Thomas Joseph ; et al.	2003-06-12
MID 4460, a human tyrosine phosphatase family member and uses therefor App 20030077638 - Logan, Thomas Joseph	2003-04-24
56919, A novel human acyltransferase and uses thereof App 20030044948 - Kapeller-Libermann, Rosana ; et al.	2003-03-06
25869, a novel human carboxylesterase and uses thereof App 20020076786 - Curtis, Rory A.J. ; et al.	2002-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.